D. Gregg, E. Khouri, and C. Rayford, Systemic and Coronary Energetics in the Resting Unanesthetized Dog. Circulation research, pp.102-115, 1965.

T. Reagan, C. Miller, D. Strandness, and J. , Transcutaneous measurement of femoral artery flow. The Journal of surgical research, pp.477-82, 1971.

S. Bevegard, U. Freyschuss, and T. Strandell, Circulatory adaptation to arm and leg exercise in supine and sitting position, Journal of applied physiology, vol.21, pp.37-46, 1966.

J. Remington and E. Wood, Formation of peripheral pulse contour in man, Journal of applied physiology, vol.9, pp.433-475, 1956.

E. Allaire and A. Clowes, Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. The Annals of thoracic surgery, pp.582-91, 1997.

J. Vane, E. Anggard, and R. Botting, Regulatory functions of the vascular endothelium, The New England journal of medicine, vol.323, pp.27-36, 1990.

A. Flammer, T. Anderson, D. Celermajer, M. Creager, J. Deanfield et al., The Assessment of Endothelial Function: From Research Into Clinical Practice, Circulation, vol.126, issue.6, pp.753-67, 2012.
DOI : 10.1161/CIRCULATIONAHA.112.093245

J. Xu and M. Zou, Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction, Circulation, vol.120, issue.13, pp.1266-86, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.835223

C. Urbich and S. Dimmeler, Endothelial Progenitor Cells, Trends in Cardiovascular Medicine, vol.14, issue.8, pp.343-53, 2004.
DOI : 10.1016/j.tcm.2004.10.001

J. Van-gils, J. Zwaginga, and P. Hordijk, Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases, Journal of Leukocyte Biology, vol.85, issue.2, pp.195-204, 2009.
DOI : 10.1189/jlb.0708400

D. Ribatti, N. B. Crivellato, and E. , The role of pericytes in angiogenesis. The International journal of developmental biology, pp.261-269, 2011.

E. Rzucidlo, K. Martin, and R. Powell, Regulation of vascular smooth muscle cell differentiation, Journal of Vascular Surgery, vol.45, issue.6, pp.25-32, 2007.
DOI : 10.1016/j.jvs.2007.03.001

S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato et al., Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant, Circulation Research, vol.89, issue.12, pp.1111-1132, 2001.
DOI : 10.1161/hh2401.100844

R. Ross and J. Glomset, Atherosclerosis and the Arterial Smooth Muscle Cell, Science, vol.180, issue.4093, pp.1332-1341, 1973.
DOI : 10.1126/science.180.4093.1332

H. Stary, A. Chandler, S. Glagov, J. Guyton, W. Insull et al., A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, vol.89, issue.5, pp.2462-78, 1994.
DOI : 10.1161/01.CIR.89.5.2462

H. Stary, A. Chandler, R. Dinsmore, V. Fuster, S. Glagov et al., A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, vol.92, issue.5, pp.1355-74, 1995.
DOI : 10.1161/01.CIR.92.5.1355

R. Virmani, F. Kolodgie, A. Burke, A. Farb, and S. Schwartz, Lessons From Sudden Coronary Death : A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.5, pp.1262-75, 2000.
DOI : 10.1161/01.ATV.20.5.1262

V. Fuster, Z. Fayad, and J. Badimon, Acute coronary syndromes: biology, The Lancet, vol.353, issue.2, pp.5-9, 1999.
DOI : 10.1016/S0140-6736(99)90234-9

F. Herisson, M. Heymann, M. Chetiveaux, C. Charrier, S. Battaglia et al., Carotid and femoral atherosclerotic plaques show different morphology, Atherosclerosis, vol.216, issue.2, pp.348-54, 2011.
DOI : 10.1016/j.atherosclerosis.2011.02.004
URL : https://hal.archives-ouvertes.fr/inserm-00642808

M. Davies, Glagovian remodelling, plaque composition, and stenosis generation, Heart, vol.84, issue.5, pp.461-463, 2000.
DOI : 10.1136/heart.84.5.461

P. Laine, M. Kaartinen, A. Penttila, P. Panula, T. Paavonen et al., Association Between Myocardial Infarction and the Mast Cells in the Adventitia of the Infarct-Related Coronary Artery, Circulation, vol.99, issue.3, pp.361-370, 1999.
DOI : 10.1161/01.CIR.99.3.361

H. Brunner, J. Cockcroft, J. Deanfield, A. Donald, E. Ferrannini et al., Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*, Journal of Hypertension, vol.23, issue.2, pp.233-279, 2005.
DOI : 10.1097/00004872-200502000-00001

A. Tedgui and Z. Mallat, Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways, Physiological Reviews, vol.86, issue.2, pp.515-81, 2006.
DOI : 10.1152/physrev.00024.2005

W. Jessup, P. Wilson, K. Gaus, and L. Kritharides, Oxidized lipoproteins and macrophages, Vascular Pharmacology, vol.38, issue.4, pp.239-287, 2002.
DOI : 10.1016/S1537-1891(02)00174-X

J. Berliner and J. Heinecke, The role of oxidized lipoproteins in atherogenesis. Free radical biology & medicine, pp.707-734, 1996.

J. Westhuyzen, The oxidation hypothesis of atherosclerosis: an update. Annals of clinical and laboratory science, pp.1-10, 1997.

I. Tabas, Nonoxidative modifications of lipoproteins in atherogenesis. Annual review of nutrition, pp.123-162, 1999.

H. Ait-oufella, S. Taleb, Z. Mallat, and A. Tedgui, Recent advances on the role of cytokines in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, pp.969-79, 2011.

I. Tabas, Cholesterol and phospholipid metabolism in macrophages, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1529, issue.1-3, pp.164-74, 2000.
DOI : 10.1016/S1388-1981(00)00146-3

L. Bottalico, N. Kendrick, A. Keller, Y. Li, and I. Tabas, Cholesteryl ester loading of mouse peritoneal macrophages is associated with changes in the expression or modification of specific cellular proteins, including increase in an alpha-enolase isoform. Arteriosclerosis and thrombosis : a journal of vascular biology, American Heart Association, vol.13, pp.264-75, 1993.

L. Larkin, L. Khachigian, and W. Jessup, Regulation of apolipoprotein E production in macrophages (review)., International Journal of Molecular Medicine, vol.6, pp.253-261, 2000.
DOI : 10.3892/ijmm.6.3.253

L. Hulten, H. Lindmark, U. Diczfalusy, I. Bjorkhem, M. Ottosson et al., Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages., Journal of Clinical Investigation, vol.97, issue.2, pp.461-469, 1996.
DOI : 10.1172/JCI118436

R. Johnson, J. Leopold, and J. Loscalzo, Vascular calcification: pathobiological mechanisms and clinical implications. Circulation research, pp.1044-59, 2006.
DOI : 10.1161/01.res.0000249379.55535.21

G. Cimmino, P. Golino, and J. Badimon, Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? Internal and emergency medicine, pp.29-34, 2011.

R. Virmani, F. Kolodgie, A. Burke, A. Finn, H. Gold et al., Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.10
DOI : 10.1161/01.ATV.0000178991.71605.18

E. Boyle, J. Lille, S. Allaire, E. Clowes, A. Verrier et al., Endothelial cell injury in cardiovascular surgery: atherosclerosis. The Annals of thoracic surgery, pp.885-94, 1997.

H. Samady, P. Eshtehardi, M. Mcdaniel, J. Suo, S. Dhawan et al., Coronary Artery Wall Shear Stress Is Associated With Progression and Transformation of Atherosclerotic Plaque and Arterial Remodeling in Patients With Coronary Artery Disease, Circulation, vol.124, issue.7, pp.779-88, 2011.
DOI : 10.1161/CIRCULATIONAHA.111.021824

M. Zimmerman and J. Mcgeachie, The effects of nicotine on aortic endothelial cell turnover and ultrastructure Advances in experimental medicine and biology, pp.79-88, 1990.

S. Lin, C. Hong, M. Chang, B. Chiang, and S. Chien, Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats Arteriosclerosis and thrombosis : a journal of vascular biology, American Heart Association, vol.12, pp.1305-1317, 1992.

T. Luscher, The Endothelium and Cardiovascular Disease -- A Complex Relation, New England Journal of Medicine, vol.330, issue.15, pp.1081-1084, 1994.
DOI : 10.1056/NEJM199404143301511

I. Takasaki, A. Chobanian, and P. Brecher, Biosynthesis of fibronectin by rabbit aorta, The Journal of biological chemistry, vol.266, pp.17686-94, 1991.

W. Hsueh and P. Anderson, Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus [clinical conference], Hypertension, vol.20, issue.2, pp.253-63, 1992.
DOI : 10.1161/01.HYP.20.2.253

L. Holdt and D. Teupser, Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arteriosclerosis, thrombosis, and vascular biology, pp.196-206, 2012.

T. Shea, R. Watson, S. Piotrowski, G. Dermksian, and R. Case, Anaerobic myocardial metabolism

A. Carrel and . Viii, ON THE EXPERIMENTAL SURGERY OF THE THORACIC AORTA AND THE HEART, Annals of Surgery, vol.52, issue.1, pp.83-95, 1910.
DOI : 10.1097/00000658-191007000-00009

M. Debakey, E. Crawford, and W. Fields, Surgical treatment of patients with cerebral arterial insufficiency associated with extracranial arterial occlusive lesions, Neurology, vol.11, issue.Issue 4, Part 2, pp.145-154, 1961.
DOI : 10.1212/WNL.11.4_Part_2.145

H. Garrett, E. Dennis, and M. Debakey, Aortocoronary bypass with saphenous vein graft. Seven-year follow-up, JAMA: The Journal of the American Medical Association, vol.223, issue.7, pp.792-796, 1973.
DOI : 10.1001/jama.223.7.792

D. Fischman, M. Leon, D. Baim, R. Schatz, M. Savage et al., A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease, New England Journal of Medicine, vol.331, issue.8, pp.496-501, 1994.
DOI : 10.1056/NEJM199408253310802

A. Cragg, G. Lund, J. Rysavy, F. Castaneda, W. Castaneda-zuniga et al., Nonsurgical placement of arterial endoprostheses: a new technique using nitinol wire., Radiology, vol.147, issue.1, pp.261-264, 1983.
DOI : 10.1148/radiology.147.1.6828742

C. Dotter, Transluminally-placed Coilspring Endarterial Tube Grafts, Investigative Radiology, vol.4, issue.5, pp.329-361, 1969.
DOI : 10.1097/00004424-196909000-00008

J. Palmaz, R. Sibbitt, F. Tio, S. Reuter, J. Peters et al., Expandable intraluminal vascular graft: a feasibility study, Surgery, vol.99, pp.199-205, 1986.

U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger, Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty, New England Journal of Medicine, vol.316, issue.12, pp.701-707, 1987.
DOI : 10.1056/NEJM198703193161201

C. Ffd, Votre coeur

T. Suzuki, G. Kopia, S. Hayashi, L. Bailey, G. Llanos et al., Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model, Circulation, vol.104, issue.10, pp.1188-93, 2001.
DOI : 10.1161/hc3601.093987

. Eurasanté, Le marché Français des implants, Bio Santé Info, vol.6, 2007.

. Cedpds, Rapport d'activité du CEPS pour 2011. www.sante.gouv.fr Juillet 2012, pp.30-31

H. Hara, M. Nakamura, J. Palmaz, and R. Schwartz, Role of stent design and coatings on restenosis and thrombosis. Advanced drug delivery reviews, pp.377-86, 2006.

S. Garg and P. Serruys, Coronary Stents, Journal of the American College of Cardiology, vol.56, issue.10, pp.43-78, 2010.
DOI : 10.1016/j.jacc.2010.06.008

J. Wataha, P. Lockwood, M. Marek, and M. Ghazi, Ability of Ni-containing biomedical alloys to activate monocytes and endothelial cellsin vitro, Journal of Biomedical Materials Research, vol.15, issue.3, pp.251-258, 1999.
DOI : 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5

O. 'brien, B. Carroll, and W. , The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review, Acta biomaterialia, vol.5, pp.945-58, 2009.

M. Vorpahl, . Le, G. Nakazawa, and R. Virmani, Overview of arterial pathology after implantation of a biomaterial, New technologies in vascular biomaterials Connecting biomaterials to arterial structures: EUROPROT, pp.1-22, 2009.

T. Kimura, K. Abe, S. Shizuta, K. Odashiro, Y. Yoshida et al., Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries, Circulation, vol.105, issue.25, pp.2986-91, 2002.
DOI : 10.1161/01.CIR.0000019743.11941.3B

A. Farb, D. Weber, F. Kolodgie, A. Burke, and R. Virmani, Morphological Predictors of Restenosis After Coronary Stenting in Humans, Circulation, vol.105, issue.25, pp.2974-80, 2002.
DOI : 10.1161/01.CIR.0000019071.72887.BD

J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes et al., Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery, New England Journal of Medicine, vol.349, issue.14, pp.1315-1338, 2003.
DOI : 10.1056/NEJMoa035071

A. Lejay, Y. Georg, C. Bajcz, F. Thaveau, B. Geny et al., Endovascular Treatment of Infra-Popliteal Arteries in Patients with Critical Limb Ischemia, Acta Chirurgica Belgica, vol.109, issue.6, pp.684-93, 2009.
DOI : 10.1080/00015458.2009.11680518

H. Dube, A. Clifford, C. Barry, D. Schwarten, and L. Schwartz, Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: Long-term results in an animal model using the TriMaxx stent, Journal of Vascular Surgery, vol.45, issue.4, pp.821-828, 2007.
DOI : 10.1016/j.jvs.2006.12.012

S. Goldberg, A. Loussararian, D. Gregorio, J. , D. Mario et al., Predictors of diffuse and aggressive intra-stent restenosis, Journal of the American College of Cardiology, vol.37, issue.4, pp.1019-1044, 2001.
DOI : 10.1016/S0735-1097(01)01107-X

I. Hsieh, C. Chien, H. Chang, M. Chern, K. Hung et al., Acute and long-term outcomes of stenting in coronary vessel > 3.0 mm, 3.0-2.5 mm, and < 2.5 mm, Catheterization and Cardiovascular Interventions, vol.44, issue.3, pp.314-336, 2001.
DOI : 10.1002/ccd.1174

A. Kastrati, S. Elezi, J. Dirschinger, M. Hadamitzky, F. Neumann et al., Influence of lesion length on restenosis after coronary stent placement. The American journal of cardiology, pp.1617-1639, 1999.

P. De-feyter, P. Kay, C. Disco, and P. Serruys, Reference Chart Derived From Post-Stent-Implantation Intravascular Ultrasound Predictors of 6-Month Expected Restenosis on Quantitative Coronary Angiography, Circulation, vol.100, issue.17, pp.1777-83, 1999.
DOI : 10.1161/01.CIR.100.17.1777

R. Kornowski, G. Mintz, K. Kent, A. Pichard, L. Satler et al., Increased Restenosis in Diabetes Mellitus After Coronary Interventions Is Due to Exaggerated Intimal Hyperplasia: A Serial Intravascular Ultrasound Study, Circulation, vol.95, issue.6, pp.1366-1375, 1997.
DOI : 10.1161/01.CIR.95.6.1366

P. Woudstra, P. Damman, M. Beijk, M. Grundeken, R. Harskamp et al., Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis, Catheterization and Cardiovascular Interventions, vol.161, issue.10 Suppl S
DOI : 10.1002/ccd.24444

M. Bennett, O. Sullivan, and M. , Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy, Pharmacology & Therapeutics, vol.91, issue.2, pp.149-66, 2001.
DOI : 10.1016/S0163-7258(01)00153-X

C. Indolfi, G. Esposito, D. Lorenzo, E. Rapacciuolo, A. Feliciello et al., Smooth Muscle Cell Proliferation Is Proportional to the Degree of Balloon Injury in a Rat Model of Angioplasty, Circulation, vol.92, issue.5, pp.1230-1235, 1995.
DOI : 10.1161/01.CIR.92.5.1230

C. Indolfi, D. Torella, C. Coppola, E. Stabile, G. Esposito et al., Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture, American Journal of Physiology - Heart and Circulatory Physiology, vol.283, issue.2, pp.760-767, 2002.
DOI : 10.1152/ajpheart.00613.2001

R. Srinivasan, R. Marchant, and A. Gupta, In vitro and in vivo platelet targeting by cyclic RGDmodified liposomes, Journal of biomedical materials research Part A, vol.93, pp.1004-1019, 2010.

A. Schober, D. Manka, P. Von-hundelshausen, Y. Huo, P. Hanrath et al., Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury, Circulation, vol.106, issue.12, pp.1523-1532, 2002.
DOI : 10.1161/01.CIR.0000028590.02477.6F

A. Gaspardone and F. Versaci, Coronary stenting and inflammation. The American journal of cardiology, pp.65-70, 2005.

A. Muto, T. Fitzgerald, J. Pimiento, S. Maloney, D. Teso et al., Smooth muscle cell signal transduction: Implications of vascular biology for vascular surgeons, Journal of Vascular Surgery, vol.45, issue.6, pp.15-24, 2007.
DOI : 10.1016/j.jvs.2007.02.061

K. Liang, S. Yin, C. Ting, S. Lin, C. Hsueh et al., Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells, European Journal of Pharmacology, vol.590, issue.1-3, pp.343-54, 2008.
DOI : 10.1016/j.ejphar.2008.06.034

A. Zalewski, Y. Shi, and A. Johnson, Diverse Origin of Intimal Cells: Smooth Muscle Cells, Myofibroblasts, Fibroblasts, and Beyond?, Circulation Research, vol.91, issue.8, pp.652-657, 2002.
DOI : 10.1161/01.RES.0000038996.97287.9A

T. Yoshida and G. Owens, Molecular Determinants of Vascular Smooth Muscle Cell Diversity, Circulation Research, vol.96, issue.3, pp.280-91, 2005.
DOI : 10.1161/01.RES.0000155951.62152.2e

J. Ferguson and C. Patterson, Break the Cycle: The Role of Cell-Cycle Modulation in the Prevention of Vasculoproliferative Diseases, Cell Cycle, vol.2, issue.3, pp.211-220, 2003.
DOI : 10.4161/cc.2.3.366

M. Servant, P. Coulombe, B. Turgeon, and S. Meloche, Expression by Mitogenic and Hypertrophic Factors, The Journal of Cell Biology, vol.1353, issue.3, pp.543-56, 2000.
DOI : 10.1038/366701a0

U. Kintscher, S. Wakino, S. Kim, S. Jackson, E. Fleck et al., Doxazosin Inhibits Retinoblastoma Protein Phosphorylation and G1->S Transition in Human Coronary Smooth Muscle Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.5
DOI : 10.1161/01.ATV.20.5.1216

R. Smith, K. Wills, D. Antelman, H. Perlman, L. Truong et al., Adenoviral Constructs Encoding Phosphorylation-Competent Full-length and Truncated Forms of the Human Retinoblastoma Protein Inhibit Myocyte Proliferation and Neointima Formation, Circulation, vol.96, issue.6, pp.1899-905, 1997.
DOI : 10.1161/01.CIR.96.6.1899

D. Marra, T. Simoncini, and J. Liao, Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1, Circulation, vol.102, issue.17, pp.2124-2154, 2000.
DOI : 10.1161/01.CIR.102.17.2124

J. Perez, R. Torres, P. Rocic, M. Cismowski, D. Weber et al., PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation, AJP: Cell Physiology, vol.301, issue.1, pp.242-51, 2011.
DOI : 10.1152/ajpcell.00315.2010

J. Liang and J. Slingerland, Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression, Cell Cycle, vol.2, issue.4, pp.339-384, 2003.
DOI : 10.4161/cc.2.4.433

S. Meloche and J. Pouyssegur, The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition, Oncogene, vol.12, issue.22, pp.3227-3266, 2007.
DOI : 10.1074/jbc.272.47.29967
URL : https://hal.archives-ouvertes.fr/hal-00319874

K. Sakakibara, K. Kubota, B. Worku, E. Ryer, J. Miller et al., PDGF-BB Regulates p27 Expression through ERK-dependent RNA Turn-over in Vascular Smooth Muscle Cells, Journal of Biological Chemistry, vol.280, issue.27, pp.25470-25477, 2005.
DOI : 10.1074/jbc.M502320200

Y. Liu, Y. Suzuki, R. Day, and B. Fanburg, Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circulation research, pp.579-86, 2004.

T. Nomiyama, T. Nakamachi, F. Gizard, E. Heywood, K. Jones et al., The NR4A Orphan Nuclear Receptor NOR1 Is Induced by Platelet-derived Growth Factor and Mediates Vascular Smooth Muscle Cell Proliferation, Journal of Biological Chemistry, vol.281, issue.44, pp.33467-76, 2006.
DOI : 10.1074/jbc.M603436200

S. Miura, Y. Matsuo, A. Kawamura, and K. Saku, JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27kip1 and Ras/p21waf1 pathways, Atherosclerosis, vol.182, issue.2, pp.267-75, 2005.
DOI : 10.1016/j.atherosclerosis.2005.02.017

Z. Xia, M. Dickens, J. Raingeaud, R. Davis, and M. Greenberg, Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis, Science, vol.270, issue.5240, pp.1326-1357, 1995.
DOI : 10.1126/science.270.5240.1326

X. Li, C. Bianchi, and F. Sellke, Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB. The Journal of surgical research, pp.197-204, 2001.

K. Bornfeldt, E. Raines, T. Nakano, L. Graves, E. Krebs et al., Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation., Journal of Clinical Investigation, vol.93, issue.3, pp.1266-74, 1994.
DOI : 10.1172/JCI117081

K. Ishikura, H. Fujita, M. Hida, and M. Awazu, Trapidil inhibits platelet-derived growth factor-induced migration via protein kinase A and RhoA/Rho-associated kinase in rat vascular smooth muscle cells, European Journal of Pharmacology, vol.515, issue.1-3, pp.28-33, 2005.
DOI : 10.1016/j.ejphar.2005.04.013

S. Martin, A. Lee, M. Williams, H. Mizuno, K. Lassegue et al., Dual regulation of cofilin activity by LIM kinase and Slingshot-1L phosphatase controls platelet-derived growth factorinduced migration of human aortic smooth muscle cells. Circulation research, pp.432-440, 2008.

G. Stankovic, A. Colombo, P. Presbitero, F. Van-den-branden, L. Inglese et al., Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial, Circulation, vol.108, issue.1, pp.37-42, 2003.
DOI : 10.1161/01.CIR.0000079106.71097.1C

O. Kwok, W. Ng, and W. Chow, Late stent thrombosis after successful rescue of a major coronary artery rupture with a polytetrafluoroethylene-covered stent, The Journal of invasive cardiology, vol.13, pp.391-395, 2001.

P. De-feyter, J. Vos, and B. Rensing, Anti-restenosis Trials. Current interventional cardiology reports, pp.326-357, 2000.

S. Venkatraman and F. Boey, Release profiles in drug-eluting stents: Issues and uncertainties, Journal of Controlled Release, vol.120, issue.3, pp.149-60, 2007.
DOI : 10.1016/j.jconrel.2007.04.022

G. Stone, S. Ellis, D. Cox, J. Hermiller, O. Shaughnessy et al., A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease, New England Journal of Medicine, vol.350, issue.3, pp.221-252, 2004.
DOI : 10.1056/NEJMoa032441

J. Sousa, M. Costa, A. Sousa, A. Abizaid, A. Seixas et al., Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries, Circulation, vol.107, issue.3, pp.381-384, 2003.
DOI : 10.1161/01.CIR.0000051720.59095.6D

K. Tsuchida, J. Piek, F. Neumann, W. Van-der-giessen, M. Wiemer et al., One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial) EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, pp.266-72, 2005.

J. Fajadet, W. Wijns, G. Laarman, K. Kuck, J. Ormiston et al., Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial, Circulation, vol.114, issue.8, pp.798-806, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.591206

M. Joner, G. Nakazawa, A. Finn, S. Quee, L. Coleman et al., Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents, Journal of the American College of Cardiology, vol.52, issue.5, pp.333-375, 2008.
DOI : 10.1016/j.jacc.2008.04.030
URL : http://doi.org/10.1016/j.jacc.2008.04.030

A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli et al., Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents, New England Journal of Medicine, vol.356, issue.10, pp.1030-1039, 2007.
DOI : 10.1056/NEJMoa067484

A. Farb, P. Heller, S. Shroff, L. Cheng, F. Kolodgie et al., Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent, Circulation, vol.104, issue.4, pp.473-482, 2001.
DOI : 10.1161/hc3001.092037

F. Kolodgie, M. John, C. Khurana, A. Farb, P. Wilson et al., Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel, Circulation, vol.106, issue.10, pp.1195-1203, 2002.
DOI : 10.1161/01.CIR.0000032141.31476.15

H. Van-beusekom, O. Sorop, M. Van-den-heuvel, Y. Onuma, D. Duncker et al., Endothelial function rather than endothelial restoration is altered in paclitaxel-as compared to bare metal-, sirolimusand tacrolimus-eluting stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, pp.117-142, 2010.

A. Finn, F. Kolodgie, J. Harnek, L. Guerrero, E. Acampado et al., Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents, Circulation, vol.112, issue.2, pp.270-278, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.508937

M. Joner, A. Finn, A. Farb, E. Mont, F. Kolodgie et al., Pathology of Drug-Eluting Stents in Humans, Journal of the American College of Cardiology, vol.48, issue.1, pp.193-202, 2006.
DOI : 10.1016/j.jacc.2006.03.042

A. Curcio, D. Torella, and C. Indolfi, Mechanisms of Smooth Muscle Cell Proliferation and Endothelial Regeneration After Vascular Injury and Stenting, Circulation Journal, vol.75, issue.6, pp.1287-96, 2011.
DOI : 10.1253/circj.CJ-11-0366

C. Plass, I. Sabdyusheva-litschauer, A. Bernhart, E. Samaha, O. Petnehazy et al., Time Course of Endothelium-Dependent and -Independent Coronary Vasomotor Response to Coronary Balloons and Stents, JACC: Cardiovascular Interventions, vol.5, issue.7, pp.741-51, 2012.
DOI : 10.1016/j.jcin.2012.03.021

S. Cook, P. Wenaweser, M. Togni, M. Billinger, C. Morger et al., Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation, Circulation, vol.115, issue.18, pp.2426-2460, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.658237

L. Ge, F. Airoldi, I. Iakovou, J. Cosgrave, I. Michev et al., Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique, Journal of the American College of Cardiology, vol.46, issue.4, pp.613-633, 2005.
DOI : 10.1016/j.jacc.2005.05.032

A. Farb, A. Burke, F. Kolodgie, and R. Virmani, Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans, Circulation, vol.108, issue.14, pp.1701-1707, 2003.
DOI : 10.1161/01.CIR.0000091115.05480.B0

E. Eisenstein, K. Anstrom, D. Kong, L. Shaw, R. Tuttle et al., Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation, JAMA, vol.297, issue.2, pp.159-68, 2007.
DOI : 10.1001/jama.297.2.joc60179

A. Finn, G. Nakazawa, M. Joner, F. Kolodgie, E. Mont et al., Vascular responses to drug eluting stents: importance of delayed healing. Arteriosclerosis, thrombosis, and vascular biology, pp.1500-1510, 2007.

R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco et al., Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?, Circulation, vol.109, issue.6, pp.701-706, 2004.
DOI : 10.1161/01.CIR.0000116202.41966.D4

Y. Otsuka, N. Chronos, R. Apkarian, and K. Robinson, Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents, The Journal of invasive cardiology, vol.19, pp.71-77, 2007.

D. Luca, G. Dirksen, M. Spaulding, C. Kelbaek, H. Schalij et al., Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials, Archives of internal medicine, vol.172, pp.611-632, 2012.

S. Bangalore, S. Kumar, M. Fusaro, N. Amoroso, M. Attubato et al., Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials, Circulation, vol.125, issue.23, pp.2873-91, 2012.
DOI : 10.1161/CIRCULATIONAHA.112.097014

M. Bosiers, D. Scheinert, P. Peeters, G. Torsello, T. Zeller et al., Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease, Journal of Vascular Surgery, vol.55, issue.2, pp.390-398, 2012.
DOI : 10.1016/j.jvs.2011.07.099

A. Rastan, E. Noory, and T. Zeller, Drug-eluting stents for treatment of focal infrapopliteal lesions, Vasa, vol.41, issue.2, pp.90-95, 2012.
DOI : 10.1024/0301-1526/a000170

P. Ho, E. Peterson, L. Wang, D. Magid, S. Fihn et al., Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome, JAMA, vol.299, issue.5, pp.532-541, 2008.
DOI : 10.1001/jama.299.5.532

G. Lemesle, F. Paparoni, C. Delhaye, L. Bonello, and J. Lablanche, Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation: A Review of the Current Guidelines and Literature, Hospital Practice, vol.160, issue.6, pp.32-40, 2011.
DOI : 10.1161/CIRCULATIONAHA.107.740324

Y. Xia, M. Prawirasatya, B. Heng, F. Boey, and S. Venkatraman, Seeding density matters: extensive intercellular contact masks the surface dependence of endothelial cell???biomaterial interactions, Journal of Materials Science: Materials in Medicine, vol.43, issue.2, pp.389-96, 2011.
DOI : 10.1007/s10856-010-4211-5

C. Tang, G. Wang, X. Wu, Z. Li, Y. Shen et al., The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents, Journal of Vascular Surgery, vol.53, issue.2, pp.461-71, 2011.
DOI : 10.1016/j.jvs.2010.08.020

J. Allen, S. Khan, M. Serrano, and G. Ameer, Characterization of porcine circulating progenitor cells: toward a functional endothelium, Tissue engineering Part A, vol.14, pp.183-94, 2008.

X. Wu, G. Wang, C. Tang, D. Zhang, Z. Li et al., Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent, Journal of Biomedical Materials Research Part A, vol.26, issue.3, pp.442-451, 2011.
DOI : 10.1002/jbm.a.33133

M. Nourse, D. Halpin, M. Scatena, D. Mortisen, N. Tulloch et al., VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arteriosclerosis, thrombosis, and vascular biology, pp.80-89, 2010.

G. Narazaki, H. Uosaki, M. Teranishi, K. Okita, B. Kim et al., Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells, Circulation, vol.118, issue.5, pp.498-506, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.769562

M. Beijk, M. Klomp, N. Verouden, N. Van-geloven, K. Koch et al., GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study, European Heart Journal, vol.31, issue.9, pp.1055-64, 2010.
DOI : 10.1093/eurheartj/ehp476

C. Tamburino, D. Capodanno, D. Salvo, M. Sanfilippo, A. Cascone et al., Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, pp.1062-1070, 2012.

S. Windecker, R. Simon, M. Lins, V. Klauss, F. Eberli et al., Randomized Comparison of a Titanium-Nitride-Oxide???Coated Stent With a Stainless Steel Stent for Coronary Revascularization: The TiNOX Trial, ACC Current Journal Review, vol.14, issue.9, pp.2617-2639, 2005.
DOI : 10.1016/j.accreview.2005.08.233

P. Hardhammar, H. Van-beusekom, H. Emanuelsson, S. Hofma, P. Albertsson et al., Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries, Circulation, vol.93, issue.3, pp.423-453, 1996.
DOI : 10.1161/01.CIR.93.3.423

D. Scheerder, I. Wang, K. Wilczek, K. Meuleman, D. Van-amsterdam et al., Experimental Study of Thrombogenicity and Foreign Body Reaction Induced by Heparin-Coated Coronary Stents, Circulation, vol.95, issue.6, pp.1549-53, 1997.
DOI : 10.1161/01.CIR.95.6.1549

Y. Matsumoto, H. Shimokawa, K. Morishige, Y. Eto, and A. Takeshita, Reduction in Neointimal Formation With a Stent Coated With Multiple Layers of Releasable Heparin in Porcine Coronary Arteries, Journal of Cardiovascular Pharmacology, vol.39, issue.4, pp.513-535, 2002.
DOI : 10.1097/00005344-200204000-00007

Y. Lee, H. Park, J. , T. Moon, H. et al., The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer???, Biomaterials, vol.28, issue.8, pp.1523-1553, 2007.
DOI : 10.1016/j.biomaterials.2006.11.020

R. Mehran, E. Aymong, D. Ashby, T. Fischell, H. Whitworth et al., Safety of an Aspirin-Alone Regimen After Intracoronary Stenting With a Heparin-Coated Stent: Final Results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) Study, Circulation, vol.108, issue.9, pp.1078-83, 2003.
DOI : 10.1161/01.CIR.0000086347.31341.F9

M. Haude, T. Konorza, U. Kalnins, A. Erglis, K. Saunamaki et al., Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients, Circulation, vol.107, issue.9, pp.1265-70, 2003.
DOI : 10.1161/01.CIR.0000053442.64637.34

Y. Hong, M. Jeong, W. Kim, S. Lim, S. Lee et al., Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries, The American Journal of Cardiology, vol.94, issue.8, pp.1050-1054, 2004.
DOI : 10.1016/j.amjcard.2004.06.066

W. Kim, M. Jeong, K. Kim, I. Sohn, Y. Hong et al., The Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute Myocardial Infarction, Journal of the American College of Cardiology, vol.47, issue.5, pp.933-941, 2006.
DOI : 10.1016/j.jacc.2005.10.054

H. Lowe, B. James, and L. Khachigian, A novel model of in-stent restenosis: rat aortic stenting, Heart, vol.91, issue.3, pp.393-398, 2005.
DOI : 10.1136/hrt.2003.028076

L. Perkins, Preclinical Models of Restenosis and Their Application to the Evaluation of Drug Eluting Stent Systems, Veterinary Pathology, vol.47, pp.58-76, 2010.
DOI : 10.1354/vp.08-VP-0294-P-REV

R. Schwartz, N. Chronos, and R. Virmani, Preclinical restenosis models and drug-eluting stents, Journal of the American College of Cardiology, vol.44, issue.7, pp.1373-85, 2004.
DOI : 10.1016/j.jacc.2004.04.060
URL : http://doi.org/10.1016/j.jacc.2004.04.060

R. Virmani, F. Kolodgie, A. Farb, and A. Lafont, Drug eluting stents, pp.133-141, 2003.
DOI : 10.1161/01.RES.84.4.378

P. Guerin, F. Rondeau, G. Grimandi, M. Heymann, D. Heymann et al., Neointimal Hyperplasia after Stenting in a Human Mammary Artery Organ Culture, Journal of Vascular Research, vol.41, issue.1, pp.46-53, 2004.
DOI : 10.1159/000076245

X. Hua, T. Deuse, E. Michelakis, A. Haromy, P. Tsao et al., Human Internal Mammary Artery (IMA) Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis, Journal of Visualized Experiments, vol.2012, issue.63, p.3663
DOI : 10.3791/3663

. Zhao-w-hz, . Jun, X. Yun, and . Bing-heng, Intravascular stent structure design oriented blood flow characteristic test device, 2009.

S. Ryter, J. Alam, and A. Choi, Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications, Physiological Reviews, vol.86, issue.2, pp.583-650, 2006.
DOI : 10.1152/physrev.00011.2005

N. Idriss, A. Blann, and G. Lip, Hemoxygenase-1 in Cardiovascular Disease, Journal of the American College of Cardiology, vol.52, issue.12, pp.971-979, 2008.
DOI : 10.1016/j.jacc.2008.06.019

L. Otterbein, F. Bach, J. Alam, M. Soares, T. Lu et al., Carbon monoxide has antiinflammatory effects involving the mitogen-activated protein kinase pathway, Nature medicine, vol.6, pp.422-430, 2000.

L. Otterbein, B. Zuckerbraun, M. Haga, F. Liu, R. Song et al., Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury, Nature Medicine, vol.9, issue.2, pp.183-90, 2003.
DOI : 10.1038/nm817

S. Brouard, L. Otterbein, J. Anrather, E. Tobiasch, F. Bach et al., Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis, The Journal of Experimental Medicine, vol.278, issue.7, pp.1015-1041, 2000.
DOI : 10.1016/S1074-7613(00)80449-5

R. Ollinger, M. Bilban, A. Erat, A. Froio, J. Mcdaid et al., Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation, Circulation, vol.112, issue.7, pp.1030-1039, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.528802

J. Balla, G. Vercellotti, V. Jeney, A. Yachie, Z. Varga et al., Heme, Heme Oxygenase, and Ferritin: How the Vascular Endothelium Survives (and Dies) in an Iron-Rich Environment, Antioxidants & Redox Signaling, vol.9, issue.12, pp.2119-2156, 2007.
DOI : 10.1089/ars.2007.1787

D. Tulis, D. W. Liu, X. Evans, A. Peyton, K. Schafer et al., Adenovirus-Mediated Heme Oxygenase-1 Gene Delivery Inhibits Injury-Induced Vascular Neointima Formation, Circulation, vol.104, issue.22, pp.2710-2715, 2001.
DOI : 10.1161/hc4701.099585

J. Deshane, S. Chen, S. Caballero, A. Grochot-przeczek, H. Was et al., Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. The Journal of experimental medicine, pp.605-623, 2007.

K. Poss and S. Tonegawa, Heme oxygenase 1 is required for mammalian iron reutilization, Proceedings of the National Academy of Sciences, vol.94, issue.20, pp.10919-10943, 1997.
DOI : 10.1073/pnas.94.20.10919

A. Yachie, Y. Niida, T. Wada, N. Igarashi, H. Kaneda et al., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency, Journal of Clinical Investigation, vol.103, issue.1, pp.129-164, 1999.
DOI : 10.1172/JCI4165

Y. Chen, L. Chau, M. Lin, L. Chen, M. Yo et al., Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting, European Heart Journal, vol.25, issue.1, pp.39-47, 2004.
DOI : 10.1016/j.ehj.2003.10.009

T. Gulesserian, C. Wenzel, G. Endler, R. Sunder-plassmann, C. Marsik et al., Clinical Restenosis after Coronary Stent Implantation Is Associated with the Heme Oxygenase-1 Gene Promoter Polymorphism and the Heme Oxygenase-1 +99G/C Variant, Clinical Chemistry, vol.51, issue.9, pp.1661-1666, 2005.
DOI : 10.1373/clinchem.2005.051581

S. Mustafa, A. Weltermann, R. Fritsche, C. Marsik, O. Wagner et al., Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism, Journal of Vascular Surgery, vol.47, issue.3, pp.566-70, 2008.
DOI : 10.1016/j.jvs.2007.09.060

B. Awede, M. Lemaire, J. Hyvelin, J. Halimi, P. Bonnet et al., Hemin, a carbon monoxide donor, improves systemic vascular compliance by inhibiting the RhoA???Rhokinase pathway in spontaneous hypertensive rats, European Journal of Pharmacology, vol.626, issue.2-3, pp.256-61, 2010.
DOI : 10.1016/j.ejphar.2009.09.045

Y. Chen, X. Zhu, X. Zhao, H. Xing, and Y. Li, Hemin, a heme oxygenase-1 inducer, improves aortic endothelial dysfunction in insulin resistant rats. Chinese medical journal, pp.241-248, 2008.

T. Chang, L. Wu, and R. Wang, Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment, AJP: Heart and Circulatory Physiology, vol.295, issue.3, pp.999-1007, 2008.
DOI : 10.1152/ajpheart.01289.2007

C. Hualin, X. Wenli, L. Dapeng, L. Xijing, P. Xiuhua et al., The Anti-inflammatory Mechanism of Heme Oxygenase-1 Induced by Hemin in Primary Rat Alveolar Macrophages, Inflammation, vol.8, issue.3, pp.1087-93, 2012.
DOI : 10.1007/s10753-011-9415-4

B. Hechler, M. Freund, G. Alame, C. Leguay, S. Gaertner et al., The antithrombotic activity of EP224283, a neutralizable dual factor Xa inhibitor/glycoprotein IIbIIIa antagonist, exceeds that of the coadministered parent compounds. The Journal of pharmacology and experimental therapeutics, pp.412-432, 2011.

J. Lynch, J. Cook, J. Sitko, G. Holahan, M. Ramjit et al., Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383, The Journal of pharmacology and experimental therapeutics, vol.272, pp.20-32, 1995.

M. Petitou, V. Nancy-portebois, G. Dubreucq, V. Motte, D. Meuleman et al., From heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile, Thrombosis and Haemostasis, vol.102, pp.804-814, 2009.
DOI : 10.1160/TH09-01-0063

P. Prandoni, D. Tormene, M. Perlati, B. Brandolin, and L. Spiezia, Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders, Expert Opinion on Investigational Drugs, vol.92, issue.5, pp.773-780, 2008.
DOI : 10.1080/07853890701320662

P. Savi, J. Herault, P. Duchaussoy, L. Millet, P. Schaeffer et al., Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy, Journal of Thrombosis and Haemostasis, vol.189, issue.Suppl. 7, pp.1697-706, 2008.
DOI : 10.1111/j.1538-7836.2008.03089.x

M. Labinaz, C. Ho, S. Banerjee, J. Martin, S. Chen et al., Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention, Canadian Journal of Cardiology, vol.23, issue.12
DOI : 10.1016/S0828-282X(07)70858-9

M. Lele, M. Sajid, N. Wajih, and G. Stouffer, Eptifibatide and 7E3, but Not Tirofiban, Inhibit ??v??3 Integrin-Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin, Circulation, vol.104, issue.5, pp.582-589, 2001.
DOI : 10.1161/hc3101.092199

R. Mehran, E. Nikolsky, E. Camenzind, M. Zelizko, I. Kranjec et al., An Internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation, American Heart Journal, vol.150, issue.6, pp.1171-1177, 2005.
DOI : 10.1016/j.ahj.2005.01.027

S. Bangalore, H. Vlachos, F. Selzer, R. Wilensky, K. Kip et al., Percutaneous coronary intervention of moderate to severe calcified coronary lesions: Insights from the National Heart, Lung, and Blood Institute Dynamic Registry, Catheterization and Cardiovascular Interventions, vol.81, issue.10 Suppl 2, pp.22-30, 2011.
DOI : 10.1002/ccd.22613

M. M. Heleen, M. Van-beusekom, D. M. Phd, . Whelan, M. Bsc et al., A practical and rapid method of histological processing for examination of coronary arteries containig metallic stents, Cardiovascular Pathology, vol.5, pp.69-76, 1996.

A. Finn, H. Gold, A. Tang, D. Weber, T. Wight et al., A Novel Rat Model of Carotid Artery Stenting for the Understanding of Restenosis in Metabolic Diseases, Journal of Vascular Research, vol.39, issue.5, pp.414-439, 2002.
DOI : 10.1159/000064518

Y. Takeda, M. Takeno, M. Iwasaki, H. Kobayashi, Y. Kirino et al., Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody, Clinical and Experimental Immunology, vol.69, issue.2, pp.237-281, 2004.
DOI : 10.1016/0098-2997(91)90005-7

B. Jaschke, C. Michaelis, S. Milz, M. Vogeser, T. Mund et al., Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform, Cardiovascular Research, vol.68, issue.3, pp.483-92, 2005.
DOI : 10.1016/j.cardiores.2005.06.029

O. 'brien, J. Wilson, I. Orton, T. Pognan, and F. , Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, European Journal of Biochemistry, vol.107, issue.17, pp.5421-5427, 2000.
DOI : 10.1046/j.1432-1327.2000.01606.x

J. Hyvelin, . Mb, R. Uzbekov, R. Motterlini, and P. Lermusiaux, Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1, Journal of Vascular Surgery, vol.51, issue.2, p.417, 2010.
DOI : 10.1016/j.jvs.2009.09.004

G. Gennaro, C. Menard, E. Giasson, S. Michaud, M. Palasis et al., Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation. Arteriosclerosis, thrombosis, and vascular biology, pp.204-214, 2003.

H. Duckers, M. Boehm, A. True, S. Yet, H. San et al., Heme oxygenase-1 protects against vascular constriction and proliferation, Nature Medicine, vol.7, issue.6, pp.693-701, 2001.
DOI : 10.1038/89068

. Vidal, NORMOSANG 25 mg/ml sol inj p perf

S. Day, J. Reeve, B. Pedersen, D. Farris, D. Myers et al., Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall, Blood, vol.105, issue.1, pp.192-200, 2005.
DOI : 10.1182/blood-2004-06-2225

M. Kroll, T. Harris, J. Moake, R. Handin, and A. Schafer, von Willebrand factor binding to platelet GpIb initiates signals for platelet activation., Journal of Clinical Investigation, vol.88, issue.5, pp.1568-73, 1991.
DOI : 10.1172/JCI115468

K. Wang, X. Zhou, Z. Zhou, N. Mal, L. Fan et al., Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury. Arteriosclerosis, thrombosis, and vascular biology, pp.1584-1593, 2005.

D. Moliterno, T. Committee, and . Investigators, A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab wi, Catheterization and Cardiovascular Interventions, vol.31, issue.7, pp.1001-1010, 2011.
DOI : 10.1002/ccd.22876

D. Faxon, T. Spiro, S. Minor, G. Cote, J. Douglas et al., Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial, Circulation, vol.90, issue.2, pp.908-922, 1994.
DOI : 10.1161/01.CIR.90.2.908

J. Lablanche, E. Mcfadden, N. Meneveau, J. Lusson, B. Bertrand et al., Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty : The FACT Study, Circulation, vol.96, issue.10, pp.3396-402, 1997.
DOI : 10.1161/01.CIR.96.10.3396

R. Kiesz, P. Buszman, J. Martin, E. Deutsch, M. Rozek et al., Local Delivery of Enoxaparin to Decrease Restenosis After Stenting: Results of Initial Multicenter Trial : Polish-American Local Lovenox NIR Assessment Study (The POLONIA Study), Circulation, vol.103, issue.1, pp.26-31, 2001.
DOI : 10.1161/01.CIR.103.1.26

I. Martin, D. Wendt, and M. Heberer, The role of bioreactors in tissue engineering, Trends in Biotechnology, vol.22, issue.2, pp.80-86, 2004.
DOI : 10.1016/j.tibtech.2003.12.001

V. Mironov, V. Kasyanov, K. Mcallister, S. Oliver, J. Sistino et al., Perfusion Bioreactor for Vascular Tissue Engineering with Capacities for Longitudinal Stretch, Journal of Craniofacial Surgery, vol.14, issue.3, pp.340-347, 2003.
DOI : 10.1097/00001665-200305000-00012

S. Yazdani and J. Berry, Development of an In Vitro System to Assess Stent-induced Smooth Muscle Cell Proliferation: A Feasibility Study, Journal of Vascular and Interventional Radiology, vol.20, issue.1, pp.101-107, 2009.
DOI : 10.1016/j.jvir.2008.09.025

S. Yazdani, B. Tillman, J. Berry, S. Soker, and R. Geary, The fate of an endothelium layer after preconditioning, Journal of Vascular Surgery, vol.51, issue.1, pp.174-83, 2010.
DOI : 10.1016/j.jvs.2009.08.074

B. Conklin, S. Surowiec, P. Lin, and C. Chen, A simple physiologic pulsatile perfusion system for the study of intact vascular tissue, Medical Engineering & Physics, vol.22, issue.6, pp.441-450, 2000.
DOI : 10.1016/S1350-4533(00)00052-7

E. Voigt, Hydrodynamic Characterization of an Arterial Flow Bioreactor

P. Guerin, Y. Goueffic, M. Heymann, P. Pillet, A. Habash et al., Direct stenting limits sirolimus-eluting stent edge neointimal thickening, Journal of Vascular Surgery, vol.46, issue.2, pp.354-363, 2007.
DOI : 10.1016/j.jvs.2007.04.063

P. Guerin, V. Sauzeau, M. Rolli-derkinderen, A. Habbash, O. Scalbert et al., Stent Implantation Activates RhoA in Human Arteries: Inhibitory Effect of Rapamycin, Journal of Vascular Research, vol.42, issue.1, pp.21-29, 2005.
DOI : 10.1159/000082873

E. Jean-baptiste, Amélioration des propriétés antibactériennes et anticoagulantes des prothèses vasculaires en polyester par immobilisation et libération contrôlée de principes actifs, TABLE DES MATIERES, 2012.

S. Resténose-intra, 32 2.3.3.1. Facteurs mécaniques impliqués dans la resténose intra stent, p.35

.. Généralités-sur-les-molécules-Étudiées, 56 1.1. L'Hémine : un inducteur et substrat de l'Hème Oxygénase 1, p.61

M. Matériels, 62 2.1. Modèles animaux de restenose intra stent, Le lapin hypercholesterolemique, p.64

.. Méthodes-d-'analyse-des-artères-stentées, 65 2.2.1. Etude histomorphometrique par microscopie optique, Western blot et Antibody Array, p.67

.. Administration-in-vivo-des-molécules-Étudiées and .. Et-bioactivité, 68 2.3.2. Répartition des lots expérimentaux d'animaux et des traitements administrés, ., p.72

/. Iib and .. Iiia-dans-la-protection-contre-la-resténose-intra-stent, Rôle de l'hème oxygénase-1 et de ses produits de dégradation

M. Matériel, 101 2.2, p.106

M. Du-bioréacteur and .. , 108 3.2.1. Cahier des charges, p.110

R. Scientifiques, . Comite, and . De, Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1

B. Maurel, F. Chai, M. Maton, N. Blanchemain, and S. Haulon, In stent restenosis and thrombosis assessment after EP224283 injection in a rat model, Atherosclerosis, vol.229, issue.2
DOI : 10.1016/j.atherosclerosis.2013.06.009

B. De, . Pour, and . Stent, Dépôt le 25 mars 2011 auprès de l'INPI. N° de dépôt : 11 52511. Pas d'extension. France: FR2973146. Désignation des inventeurs : Mme Maurel

C. Orales and S. Sur, Heme oxygenase-1 induction prevents in-stent restenosis in rat and rabbit models

B. Maurel, D. Antier, P. Lermusiaux, and J. Hyvelin, POSTERS ? Intra stent restenosis : what are the effects of heme oxygenase-1 induction ? Endocoronary Biomechanics Research Symposium, 2008.

B. Maurel, . Lermusiaux, J. Antier, and . Hyvelin, Effets de l'hémine sur l'hyperplasie myointimale intra-stent chez le rat, Printemps de la Cardiologie. 28-29 Mai, 2008.

D. De, Dotation de Recherche de l'Institut de l'Athérothrombose. Mars Montant : 24 000 ?. Projet : Hyperplasie myointimale intra-stent : effet de l, 2008.

?. Dotation-de-recherche, de la Société de Chirurgie Vasculaire de langue Française, Montant : 9 500 ?. Projet : Artères coronaires et artères de jambe : différences physiologiques et conséquences sur la resténose intra-stent, 2008.